NYSE · AIR

AAR Corp.

$129.05 -$0.42 (-0.32%) 1D After hours

Key Metrics

$5.15B
Market cap
30.11×
P/E · TTM
Revenue · TTM
$171.00M
Net income
EPS · TTM $4.50
Dividend yield
Free cash flow $60.20M
Beta · 1Y 1.70
EBITDA · TTM $291.90M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    Offering paper hit the record (Form S-3).

    S-3ASR - AAR CORP (0000001750) (Filer)

    RECEIPT: SEC FORM S-3, TIMESTAMPED
  • Jul 22
    The stock moved -9.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 22
  • Jul 21
    A material event was filed (Form 8-K).

    8-K - AAR CORP (0000001750) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 25
    The stock moved +9.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.15B
Enterprise value$5.96B
Shares outstanding39.9M
52-wk range$71.43 – $146.75
Avg volume · 20D310.3K
Net cash −$809.80M
Book value / share$43.25
IndustryAircraft & Parts
ExchangeNYSE
About AAR Corp.
IPO dateJun 1, 1972
Employees7100

AAR Corp offers a broad line of products and services to commercial and government aerospace customers and operates internationally.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E30.11
P/S
P/FCF85.52
EV/EBITDA20.41
EV/Sales
Graham №$66.17

Profitability

Gross
Operating
Net
FCF
ROE / ROIC 12.1% · —

Financial Health

Current ratio2.70
Quick ratio1.23
Debt / equity0.54
Debt / EBITDA 3.04
Net cash −$809.80M
Working capital$1.11B

Cash Flow · TTM

Operating CF $94.80M
Capex −$34.60M
Free cash flow $60.20M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$66.17 vs $129.05
Trades 2.0× above classic defensive value — priced for growth
Fundamentals through 2026-02-28 · computed by TickerWolf from SEC filings